These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11132184)

  • 1. Human, but not bovine, oxidized cerebral spinal fluid lipoproteins disrupt neuronal microtubules.
    Neely MD; Swift LL; Montine TJ
    Lipids; 2000 Nov; 35(11):1249-57. PubMed ID: 11132184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid lipoproteins in Alzheimer's disease.
    Bassett CN; Montine KS; Neely MD; Swift LL; Montine TJ
    Microsc Res Tech; 2000 Aug; 50(4):282-6. PubMed ID: 10936881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid lipoprotein delivery to human neuronal cells is increased in Alzheimer's disease and is dependent on apoE monomer concentration.
    Bassett CN; Swift LL; Montine KS; Markesbery WR; Montine TJ
    J Alzheimers Dis; 2002 Feb; 4(1):19-30. PubMed ID: 12214015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo.
    Bassett CN; Neely MD; Sidell KR; Markesbery WR; Swift LL; Montine TJ
    Lipids; 1999 Dec; 34(12):1273-80. PubMed ID: 10652986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human apolipoprotein E accelerates microtubule polymerization in vitro.
    Scott BL; Welch K; deSerrano V; Moss NC; Roses AD; Strittmatter WJ
    Neurosci Lett; 1998 Apr; 245(2):105-8. PubMed ID: 9605496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophoretic studies on the phosphorylation of stathmin and mitogen-activated protein kinases in neuronal cell death induced by oxidized very-low-density lipoprotein with apolipoprotein E.
    Yamashita H; Nakamura K; Arai H; Furumoto H; Fujimoto M; Kashiwagi S; Morimatsu M
    Electrophoresis; 2002 Apr; 23(7-8):998-1004. PubMed ID: 11981845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased lipoprotein oxidation in Alzheimer's disease.
    Schippling S; Kontush A; Arlt S; Buhmann C; Stürenburg HJ; Mann U; Müller-Thomsen T; Beisiegel U
    Free Radic Biol Med; 2000 Feb; 28(3):351-60. PubMed ID: 10699746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF lipoproteins and Alzheimer's disease.
    Neely MD; Montine TJ
    J Nutr Health Aging; 2002; 6(6):383-91. PubMed ID: 12459889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain lipoprotein metabolism and its relation to neurodegenerative disease.
    Danik M; Champagne D; Petit-Turcotte C; Beffert U; Poirier J
    Crit Rev Neurobiol; 1999; 13(4):357-407. PubMed ID: 11028681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lipid peroxidation product 4-hydroxynonenal inhibits neurite outgrowth, disrupts neuronal microtubules, and modifies cellular tubulin.
    Neely MD; Sidell KR; Graham DG; Montine TJ
    J Neurochem; 1999 Jun; 72(6):2323-33. PubMed ID: 10349841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluid.
    Borghini I; Barja F; Pometta D; James RW
    Biochim Biophys Acta; 1995 Mar; 1255(2):192-200. PubMed ID: 7696334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-course of oxidation of lipids in human cerebrospinal fluid in vitro.
    Arlt S; Finckh B; Beisiegel U; Kontush A
    Free Radic Res; 2000 Feb; 32(2):103-14. PubMed ID: 10653481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin E in neurodegenerative disorders: Alzheimer's disease.
    Kontush K; Schekatolina S
    Ann N Y Acad Sci; 2004 Dec; 1031():249-62. PubMed ID: 15753151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remodelling of cerebrospinal fluid lipoproteins after subarachnoid hemorrhage.
    Kay AD; Day SP; Nicoll JA; Packard CJ; Caslake MJ
    Atherosclerosis; 2003 Sep; 170(1):141-6. PubMed ID: 12957692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and functions of human cerebrospinal fluid lipoproteins from individuals of different APOE genotypes.
    Rebeck GW; Alonzo NC; Berezovska O; Harr SD; Knowles RB; Growdon JH; Hyman BT; Mendez AJ
    Exp Neurol; 1998 Jan; 149(1):175-82. PubMed ID: 9454626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nascent astrocyte particles differ from lipoproteins in CSF.
    LaDu MJ; Gilligan SM; Lukens JR; Cabana VG; Reardon CA; Van Eldik LJ; Holtzman DM
    J Neurochem; 1998 May; 70(5):2070-81. PubMed ID: 9572293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microsequencing of bovine cerebrospinal fluid apolipoproteins: identification of bovine apolipoprotein E.
    Puppione DL; Fischer WH; Park M; Gazal OS; Williams GL
    Lipids; 1998 Aug; 33(8):781-6. PubMed ID: 9727608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble LR11 competes with amyloid β in binding to cerebrospinal fluid-high-density lipoprotein.
    Yano K; Hirayama S; Misawa N; Furuta A; Ueno T; Motoi Y; Seino U; Ebinuma H; Ikeuchi T; Schneider WJ; Bujo H; Miida T
    Clin Chim Acta; 2019 Feb; 489():29-34. PubMed ID: 30448281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro.
    Vuletic S; Peskind ER; Marcovina SM; Quinn JF; Cheung MC; Kennedy H; Kaye JA; Jin LW; Albers JJ
    J Neurosci Res; 2005 May; 80(3):406-13. PubMed ID: 15795933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remodeling of cerebrospinal fluid lipoprotein particles after human traumatic brain injury.
    Kay AD; Day SP; Kerr M; Nicoll JA; Packard CJ; Caslake MJ
    J Neurotrauma; 2003 Aug; 20(8):717-23. PubMed ID: 12965051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.